Nexus AG Company Description

Nexus AG develops and sells software solutions for the healthcare market in Germany, Switzerland, Liechtenstein, the Netherlands, Poland, France, Austria, and internationally.

The company operates through NEXUS / DE; NEXUS / DIS; and NEXUS / ROE segments. It offers hospitals information systems, mobile solutions, digital charts and medication, PDMS and device connection, care documentation, appointment and resource management, OP management and CSSD, emergency, medical archive and VNA, patient portal, and diagnostics solutions for hospitals and clinics.

The company also provides human genetics, molecular pathology, HBOC, specialized laboratories, special diagnostics, gynecological hospital, ophthalmology, advanced reporting, MARIS healthcare GmbH, and ViREQ software solutions GmbH solutions for diagnostics.

In addition, it offers radiology and VNA solutions consisting of radiology information system, vendor neutral archive, PACS, teleradiology portal, telemedicine portal, referral portal, patient portal for images and diagnostic findings, webviewer, telemedicine networking, and DICOM RT-viewer; and residential and psychiatry solutions.

Further, the company provides pathology, cytology, and laboratory solutions, as well as IT services comprising integrated solutions.

NEXUS AG was founded in 1989 and is headquartered in Donaueschingen, Germany.

Nexus AG

Country	Germany
Founded	1989
Industry	Health Information Services
Sector	Healthcare
Employees	1,909
CEO	Ingo Behrendt

Contact Details

Address: Irmastrasse 1 Donaueschingen, 78166 Germany
Phone	49 771 22960 0
Website	nexus-ag.de

Stock Details

Ticker Symbol	NXU
Exchange	Deutsche Börse Xetra
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	DE0005220909
SIC Code	7370

Key Executives

Name	Position
Dr. Ingo Behrendt MBA	Chairman of the Executive Board and Chief Executive Officer
Ralf Heilig M.B.A.	Chief Sales Officer and Member of the Executive Board
Edgar Kuner	Chief Development Officer and Member of Executive Board
Melanie Ilic	Head of Investor Relations